Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Core Laboratories (CLB) Other Gross PP&E Adjustments (2022 - 2026)

Core Laboratories filings provide 5 years of Other Gross PP&E Adjustments readings, the most recent being -$54.7 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 4.84% to -$54.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$54.7 million, a 4.84% increase, with the full-year FY2025 number at -$54.3 million, up 3.79% from a year prior.
  • Other Gross PP&E Adjustments hit -$54.7 million in Q1 2026 for Core Laboratories, down from -$54.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$52.4 million in Q4 2022 to a low of -$57.5 million in Q1 2025.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$54.7 million (2026), compared with a mean of -$54.8 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: fell 7.19% in 2025 and later grew 4.84% in 2026.
  • Core Laboratories' Other Gross PP&E Adjustments stood at -$52.4 million in 2022, then dropped by 2.79% to -$53.8 million in 2023, then dropped by 4.91% to -$56.5 million in 2024, then grew by 3.79% to -$54.3 million in 2025, then decreased by 0.67% to -$54.7 million in 2026.
  • The last three reported values for Other Gross PP&E Adjustments were -$54.7 million (Q1 2026), -$54.3 million (Q4 2025), and -$54.0 million (Q3 2025) per Business Quant data.